A. MohanaSundaram, G. Kesavan, K. Nagaraj, and P. Ramesh, “Donanemab for Alzheimer’s disease: a translational milestone or just another chapter in the anti-amyloid antibody story?”, Am J Transl Med, vol. 9, no. 3, pp. 104–109, Sep. 2025.